Alzheimer Disease Drug Lecanemab Successfully Reduces Cognitive, Functional Decline

September 28th 2022, 2:38pm


The topline results showed the phase 3 trial met both the primary endpoint and all secondary endpoints.

Dr Paul Forsberg: Ensuring Consistent, Clear Messaging Critical During Biosimilar Conversion

September 25th 2022, 1:52pm


When converting a patient to a biosimilar, having clear and consistent messaging will reduce confusion and prevent patients from having a lack of trust in the process, said Paul Forsberg, PharmD, director of pharmacy, Minnesota Oncology.

Evaluating Factors Associated With Treatment Satisfaction in Hidradenitis Suppurativa

September 24th 2022, 7:20pm


Tobacco smoking, depression, and increasing number of comorbidities were associated with reduced treatment satisfaction among patients with hidradenitis suppurativa.

Contributor: The Mental Health Crisis, How We Got Here, and Where We Go Next

September 22nd 2022, 5:11pm


Addressing the mental health crisis in the United States warrants innovation in treatment and recovery, and the development of mechanisms to provide and pay for them accordingly.

Moonshot 2.0 Looks to Focus on Caregivers, Learn From Patients

September 21st 2022, 2:01pm


Danielle Carnival, PhD, addressed the National Comprehensive Cancer Network Policy Summit on Friday.

Contributor: Sustaining the “New Normal”—The Future Is Still Bright for Telehealth in the Wake of COVID-19

September 21st 2022, 1:40pm


Consumers want telehealth and telehealth can help achieve organizational goals of avoiding unplanned care, closing care gaps, and achieving care targets.

Stakeholders Address Innovative Strategies Driving Cancer Outcomes in New Jersey

September 20th 2022, 9:40pm


Key stakeholders involved in the delivery of cancer care in New Jersey discuss strategies driving innovation in oncology and remaining challenges impeding their integration at the 70th Annual Roy A. Bowers Pharmaceutical Conference.

Contributor: The Future of Prior Authorization Under the Improving Seniors’ Timely Access to Care Act

September 20th 2022, 3:04pm


Streamlining the prior authorization process can improve care accuracy and patient access to care, writes Siva Namasivayam, CEO of Cohere Health.

Insurers Negotiate Lower Hospital Prices for HIX Than for Commercial Groups

September 15th 2022, 1:00pm


Hospital price transparency data suggest that health insurance exchange (HIX) plans get lower negotiated rates than commercial group plans and higher negotiated rates than Medicare Advantage plans.

Recent NCCN Update Moves Zanubrutinib Ahead of Ibrutinib in CLL/SLL Based on Toxicity Profile

September 11th 2022, 3:04pm


The National Comprehensive Cancer Network recommendations come as the FDA weighs an indication in chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) for zanubrutinib.